Finecure Pharmaceuticals Limited, a active public limited company, was established on 18 March 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PLC045724. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹12.71 Cr.
It upholds a compliant status. Employing 454 professional, Its leadership includes Vivek Rajgarhia (Whole-Time Director), Vishal Haremurari Rajgarhia (Whole-Time Director), Vikash Rajgarhia (Managing Director). Past directors included Vivek Rajgarhia, Vishal Haremurari Rajgarhia, Vikash Rajgarhia. It holds ₹65.19 Cr open charges and ₹26.58 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-1201, Mondeal Heights, Nr. Wide Angle, S.G. Highway,, Ahmedabad, Gujarat, 380015.
U24230GJ2005PLC045724
045724
18 March 2005
₹20.00 Cr
₹12.71 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Finecure Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Rajgarhia | Whole-Time Director | 18 Mar 2005 | Current |
| Vishal Haremurari Rajgarhia | Whole-Time Director | 18 Mar 2005 | Current |
| Vikash Rajgarhia | Managing Director | 18 Mar 2005 | Current |
| Niraj Kumar Harodia | Director | 28 Jan 2025 | Current |
| Anshu Krishnakumar Agrawal | Director | 21 Dec 2017 | Current |
| Mukesh Tarachand Agarwal | Director | 21 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 21 Dec 2017 | Past |
| Pramod Abcsdd | Director | 21 Dec 2017 | Past |
| Pramod Abcsdd | Director | 05 Feb 2018 | Past |
| Pramod Abcsdd | Director | 01 Nov 2024 | Past |
| Pramod Abcsdd | Director | 08 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Finecure Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial fall in profitability, with a 30.02% decrease in profit. The company's net worth moved up by a moderate rise of 5.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Finecure Pharmaceuticals had a promoter holding of 96.85% and a public holding of 3.15%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹651,947,664.00
₹265,821,859.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Sep 2023 | Others | ₹5.90 Cr | Open |
| 24 Mar 2023 | Sidbi | ₹1.89 Cr | Open |
| 04 Mar 2020 | Sidbi | ₹22.32 Cr | Open |
| 23 Jul 2019 | Standard Chartered Bank | ₹35.00 Cr | Open |
| 10 Jun 2014 | Others | ₹0.88 M | Open |
Explore comprehensive loan charge details -
Finecure Pharmaceuticals has a workforce of 454 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Finecure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finecure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 12 Jan 2023 via Charge ID 100672344 with State Bank Of India was fully satisfied on 04 Dec 2025. was recorded as a recent event.
Finecure Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge with Sidbi of Rs. 22.32 Cr registered on 04 Mar 2020 with Charge ID 100332311 was modified on 26 May 2025. was completed.
The activity Finecure Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity Niraj Kumar Harodia was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 11 months 18 days . was completed.
A charge registered on 25 Mar 2022 via Charge ID 100561303 with Bank Of India was fully satisfied on 27 Nov 2024. was recorded as a recent event.
The CIN of Finecure Pharmaceuticals Limited is U24230GJ2005PLC045724.
Finecure Pharmaceuticals Limited is headquartered at A-1201, Mondeal Heights, Nr. Wide Angle, S.G. Highway,, Ahmedabad, Gujarat, 380015.
Finecure Pharmaceuticals Limited was incorporated on 18 March 2005.
The current directors of Finecure Pharmaceuticals Limited are
The primary industry of Finecure Pharmaceuticals Limited is Manufacturing.
Finecure Pharmaceuticals Limited is unlisted.
The authorized capital of Finecure Pharmaceuticals Limited is ₹20.00 Cr, and the paid-up capital is ₹12.71 Cr.
The compliance status of Finecure Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX